Natalizumab induces and maintains continuous response and remission in patients with active Crohn's disease despite prior anti-tumor necrosis factor-alpha treatment

  • R Panaccione
  • , J Colombel
  • , R Enns
  • , B Feagan
  • , S Hanauer
  • , Ian Lawrance
  • , P Rutgeerts
  • , W Sandborn
  • , S Schreiber
  • , S Targan
  • , S Van Deventer

    Research output: Chapter in Book/Conference paperConference paper

    1 Citation (Web of Science)
    Original languageEnglish
    Title of host publicationINFLAMMATORY BOWEL DISEASES
    PagesS10-S10
    Volume14
    Publication statusPublished - 2008
    EventNatalizumab induces and maintains continuous response and remission in patients with active Crohn's disease despite prior anti-tumor necrosis factor-alpha treatment -
    Duration: 1 Jan 2008 → …

    Conference

    ConferenceNatalizumab induces and maintains continuous response and remission in patients with active Crohn's disease despite prior anti-tumor necrosis factor-alpha treatment
    Period1/01/08 → …

    Cite this